For many years, physics studies focused on two main types of magnetism, namely ferromagnetism and antiferromagnetism. The ...

Quantum promises huge breakthroughs in drug discovery and last-mile delivery, but there are still unknowns about what a world in quantum’s hands will mean.

Needham & Company LLC reaffirmed their buy rating on shares of D-Wave Quantum (NYSE:QBTS – Free Report) in a report issued on Wednesday,Benzinga reports. The firm currently has a $8.50 target price on ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Craig-Hallum analyst Richard Shannon reiterated a Buy rating on D-Wave Quantum (QBTS – Research Report) today and set a price target of $9.00.

D-Wave Quantum Inc. (NYSE:QBTS – Get Free Report) has received a consensus recommendation of “Buy” from the six ratings firms ...

Quantum computing is rapidly emerging as the next great revolution in technology, a field that could one day outpace artificial intelligence (AI) in terms of disruptive potential. This year is proving ...

In a report released today, Sujeeva De Silva from Roth MKM maintained a Buy rating on D-Wave Quantum (QBTS – Research Report), with a price ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.38, with a high ...

A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect ...

Quantum computing systems and software company D-Wave Quantum Inc. has partnered with the pharmaceutical division of Japan ...

D-Wave Quantum Inc has deployed its hybrid approach to solve optimization problems and drug discovery hurdles in separate projects.